HK IPOs continue at breakneck pace

A throat lozenges manufacturer, a brokerage and a private obstetrics and gynaecology hospital group are all seeking to float shares in Hong Kong.
Golden Throat began pre-marketing ahead of its Hong Kong listing.
Golden Throat began pre-marketing ahead of its Hong Kong listing.

Hong Kong’s IPO market continues at a breakneck pace, with a number of issuers launching IPOs on June 22 amid volatile markets.

Harmonicare Medical Holdings, a private obstetrics and gynaecology hospital group in China, is looking to raise up to HK$1.6 billion $202 million in its flotation.

Futures firm Luzheng Futures Company meanwhile is seeking just over HK$1 billion pre-greenshoe in its IPO, while Golden Throat Holdings, a lozenges manufacturer, began pre-marketing ahead of its own Hong Kong listing.

The IPOs come amid severe turbulence in A-share markets. Last week the Shanghai Stock Exchange Composite Index fell nearly 12%....

¬ Haymarket Media Limited. All rights reserved.

FinanceAsia has updated its subscription model.

Registered readers now have the opportunity to read 5 articles from our award-winning website for free.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences.

To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222

Article limit is reached.

Hello! You have used up all of your free articles on FinanceAsia.

To obtain unlimited access to our award-winning exclusive news and analysis, we offer subscription packages, including single user, team (2-10 users), or office-wide licences. To help you and your colleagues access our proprietary content, please contact us at subscriptions@financeasia.com, or +(852) 2122 5222